Canadian MPN Research Foundation

The Canadian MPN Research Foundation funds research into myeloproliferative neoplasms, a group of rare blood cancers that affect the bone marrow's ability to produce blood cells. The foundation supports clinical trials and laboratory studies across Canadian institutions, including hospitals throughout Toronto and the GTA, to improve treatment options and patient outcomes. Beyond research, the organization connects patients with information about their diagnosis, available therapies, and emerging clinical trials, helping them navigate what is often a complex and lifelong condition. The foundation also advocates for faster drug approvals and improved access to medications for MPN patients in Canada, working with healthcare providers and policymakers to address gaps in care and treatment availability.